APA citiranje

IIMORI, N., KASHIWAGI, S., ASANO, Y., GOTO, W., TAKADA, K., TAKAHASHI, K., . . . OHIRA, M. (2018). Clinical Significance of the Neutrophil–to–Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer. In Vivo.

Citação norma Chicago

IIMORI, NOZOMI, et al. "Clinical Significance of the Neutrophil–to–Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer." In Vivo 2018.

MLA citiranje

IIMORI, NOZOMI, et al. "Clinical Significance of the Neutrophil–to–Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer." In Vivo 2018.